🚀
Enjoy a 7-Day Free Trial Thru May 04, 2024!
✨
Sign Up
Login
Free Sign-up
Login
7-Day Free Trial
Home
Homepage
Membership Levels
About Us
General Discussion
Complete Stock List
The book
Membership Data Coverage
Founder's Message
Free Trial
Referral Program
Partner Program
GuruFocus Podcast
Screeners
GuruFocus Screeners
All-In-One Screener
Ben Graham Lost Formula
Canadian Faster Growers
CEO Buys
CEO Buys after Price Drop > 20%
Dividend Kings 2023
Dividend Aristocrats 2023
Dividend Growth Portfolio
Dividend Income Portfolio
Fast Growers
Good Companies
Hedge Fund Guru Top 10 Aggregated
High Quality
High Quality Low Capex w ROE ROC min
High Quality & Low Capex
High Yield Insider Buys
Historical High Dividend Yields
International Gurus' Top Holdings
James Montier Short Screen
Margin Decliners
Mega Caps
Peter Lynch & Warren Buffett
Peter Lynch Growth w Lower Valuation
Peter Lynch S&L Traded Below Book
PFCF Screener
Piotroski Score Screener
Predictable Growth Companies
Profitable predictable margin expanders
Stocks Sold w less Cash
The Stalwarts
My Screeners
Create My Screener
Value Screens
Stock Ideas
All-In-One Screener
S&P 500 Map
S&P 500 Bubble
S&P 500 Aggregate
Buffett-Munger Screener
Industry Overview
Undervalued Predictable
Benjamin Graham Net-Net
52-week/3Y/5Y Lows
52-week/3Y/5Y Highs
Magic Formula(Greenblatt)
Dividend Stocks
Peter Lynch Screen
S&P500 Grid
Predictable Companies
Spin Off List
Merger and Acquisition List
Historical Low P/B List
Historical Low P/S List
High Short Interest
Upcoming Special Dividends
Delisted Stocks
Model Portfolios
Performances Overview
Most Broadly Held Portfolio
Most Weighted Portfolio
Buffett-Munger Top 25
GF Score <= 100 Top 25
Top 25 Undervalued Predictable
Top 25 52-week Low Predictable
Top 25 Historical Low P/S
Stock Comparison
Airline Stocks
Artificial Intelligence Stocks
Bank Stocks
Biotech Stocks
Blockchain Stocks
Chinese Stocks
Dividend Stocks
EV Stocks
Growth Stocks
Oil Stocks
Value Stocks
Virtual Reality Stocks
Compare More Stocks…
Gurus
Guru Trades
Latest Guru Picks
Real Time Picks
Guru Portfolio
Score Board
Mutual Funds
Top 10 Holdings
Sector Picks
International Picks
Aggregated Portfolio
Consensus Picks
Guru Bargains
Hot Picks
Download Guru Portfolios
Industry Trends
Geographic Trend
ETFs
Options Holdings
European Shorting
Guru Lists
Complete Guru List
Warren Buffett
Bill Gates
Mohnish Pabrai
Carl Icahn
George Soros
David Tepper
Seth Klarman
Bill Ackman
Joel Greenblatt
Charlie Munger
Michael Price
Julian Robertson
Chuck Akre
David Einhorn
Tom Gayner
My Guru Lists
Insiders
Insider Trading Tracker
Real-Time Insider Picks
CEO Buys/Sells
CFO Buys/Sells
Insider Trends
Insider Cluster
Guru + Insider Double Buys
Triple Buys/Sells
Chinese Insider
German Insider
Complete Insider List
Politician Trading Tracker
Real-Time Politician Picks
Complete Politician List
Nancy Pelosi
Mitch Mcconnell
Tommy Tuberville
Josh Gottheimer
Kevin Hern
Thomas R. Carper
Susie Lee
Lois Frankel
Market
US Market Valuation
Buffett Indicator
U.S. Treasury Yield Curve
U.S. Inflation Rate
Presidential Cycle and Stock Market
Shiller P/E
Shiller P/E by Sectors
GF Value for S&P 500 Index
Fed Net Liquidity
Buffett Assets Allocation
Latest IPOs
Global Market Valuation
Global Market Overview
USA
China
Japan
India
Canada
UK
France
Germany
Brazil
Australia
More...
Economic Indicators
Economic Indicators Overview
The Dow Jones Industrial Average (DJIA)
SP 500 Index
Nasdaq Composite Index
Gross Domestic Product (GDP)
Shiller PE
Ratio of Wilshire 5000 over GNP
Civilian Unemployment Rate
Russell 2000 Index
CBOE Volatility Index (VIX)
Total Nonfarm Payrolls: All Employees
More...
Sector & Industry Performance
Global Industry Overview
USA
Asia
Europe
Canada
UK/Ireland
Oceania
Latin America
Africa
India/Pakistan
Articles
Articles
Editors' Picks
Stock Market News
Q&A with Gurus
Guru Stock Picks
Insider Transaction
Earning Reports
CEO Shareholder Letters
Podcast
Earnings Call Transcripts
Software Stock News
Biotechnology Stock News
Hardware Stock News
Banks Stock News
Metals & Mining Stock News
Drug Manufacturers Stock News
All Articles
Submit Articles
Submit Article Online
Contributor Guidelines
Tools
Model Portfolios
All-In-One Screener
Data Batch Download
Guru Portfolio Download
Insider Data Download
Excel Add-In
Google Sheets Add-On
API
Manual of Stocks
DCF Calculator
WACC Calculator
Interactive Chart
Maps
Fund Letters Archive
Stock Comparison Table
Mobile App
Discussion Board
GuruGPT
Financial Calendar
Embed Widgets
Stock Market Holidays
Discussion
Discussion Board
GuruFocus Discord
ETF
Data
Pricing
Tutorials
Tutorials
Financial Glossary
FAQ
Change Log
Contact Us
Support
Chat Support
Create a ticket
Book Demo
User Engagement Meeting
469-248-6885
Status
Take Survey
Ask the community in Discord
Subscribe
Free Trial
Group Subscription
Refer a Friend and Earn One Month of Free Membership
GURUFOCUS.COM
STOCK LIST
Healthcare
Biotechnology
AIM ImmunoTech Inc (AMEX:AIM)
News
AIM ImmunoTech Inc
AMEX
:AIM (USA) Â
$ 0.43
+0.0217 (+5.34%)
10:08 PM EST
P/E:
At Loss
P/B:
2.25
Market Cap:
$ 21.73M
Enterprise V:
$ 8.97M
Volume:
82.22K
Avg Vol (2M):
263.91K
Warning! GuruFocus detected 5 Severe warning signs with AIM.
Try a 7-Day Free Trial
to check it out.
Also Trade In:
Volume:
82.22K
Market Cap $:
21.73M
PE Ratio:
At Loss
Avg Vol (2M):
263.91K
Enterprise Value $:
8.97M
PB Ratio:
2.25
Alerts
Website
SEC Filings
Stock PDF
Dataset
Financial Download
Manual of Stocksâ„¢
Compare
0
Summary
30-Y Financials
Estimates
DCF
Dividend
Guru Trades
Insider
Interactive Chart
Filings
Transcripts
News
Compare
Stock PDF
Ownership
Operating
Checklist
Vote
Definitions
AIM ImmunoTech Inc (AMEX:AIM) Stock News, Headlines & Updates
AIM ImmunoTech Inc Stock News from GuruFocus
Total 79
1
2
Apr 03, 2024
Q4 2023 AIM ImmunoTech Inc Earnings Call Transcript
GuruFocus Research
•
11:00pm
Feb 12, 2024
AIM ImmunoTech Inc at HC Wainwright Investment Conference - New York Transcript
GuruFocus Research
•
10:54am
Q2 2023 AIM ImmunoTech Inc Earnings Call Transcript
GuruFocus Research
•
10:54am
AIM ImmunoTech Inc Investor Summer Spotlight Series Transcript
GuruFocus Research
•
10:54am
Q1 2023 AIM ImmunoTech Inc Earnings Call Transcript
GuruFocus Research
•
10:54am
Q4 2022 AIM ImmunoTech Inc Earnings Call Transcript
GuruFocus Research
•
10:54am
AIM ImmunoTech Inc at H C Wainwright Global Investment Conference (Virtual) Transcript
GuruFocus Research
•
10:54am
AIM ImmunoTech Inc at JTC Team Top Picks Virtual Investor Conference Transcript
GuruFocus Research
•
10:54am
AIM ImmunoTech Inc at SNN Network Virtual Conference Transcript
GuruFocus Research
•
10:54am
AIM ImmunoTech on Commercial Launch in Argentina for Chronic Fatigue and COVID-19 Clinical Trials- Corporate Analyst Meeting Transcript
GuruFocus Research
•
10:54am
CEO Roadshow Interview: Thomas Equels, CEO of AIM Immunotech Corporate Analyst Meeting Transcript
GuruFocus Research
•
10:54am
AIM ImmunoTech greenlit to import chronic fatigue syndrome drug into Argentina Corporate Analyst Meeting Transcript
GuruFocus Research
•
10:54am
AIM ImmunoTech Inc To Describe Their Approach and Progress with Ampligen to Combat COVID-19 Transcript
GuruFocus Research
•
10:54am
AIM ImmunoTech Inc at SNN Planet MicroCap Showcase Transcript
GuruFocus Research
•
10:54am
Jan 03, 2024
Kellner Seeking Expedited Appeal of Delaware Court Finding that Nomination Notice was Properly Denied
PRNewswire
•
4:00pm
Jan 04, 2023
Could Insider Buying Signal that AIM ImmunoTech Inc Is Undervalued?
GuruFocus Research
•
12:30pm
Could Insider Buying Signal that AIM ImmunoTech Inc Is Undervalued?
GuruFocus Research
•
12:30pm
Dec 24, 2020
AIM ImmunoTech Announces Availability of the ME/CFS Clinical Trial of its Drug Ampligen for Enrollment to COVID-19 Long Haulers
ACCESSWIRE
•
7:00am
Dec 21, 2020
Thinking about buying stock in Nantkwest, RealPage, Aerojet Rocketdyne, AIM ImmunoTech, or Corbus Pharmaceuticals?
PRNewswire
•
11:02am
Dec 18, 2020
Thinking about buying stock in Vistagen Therapeutics, Adapthealth, PainReform, Arbutus Biopharma, or AIM ImmunoTech?
PRNewswire
•
11:02am
Sep 22, 2020
Thinking about buying stock in AIM ImmunoTech, Rockwell Medical, Transocean, Aurora Cannabis, or Wayfair?
PRNewswire
•
11:04am
AIM ImmunoTech Receives Statistically Significant Positive Survival Results in Pancreatic Cancer from Erasmus University Medical Center, Rotterdam, Netherlands
ACCESSWIRE
•
7:00am
Sep 16, 2020
AIM ImmunoTech Highlights Start of Recruitment in Roswell Park Clinical Trial Incorporating Ampligen in the Treatment of Cancer Patients with Mild or Moderate COVID-19
ACCESSWIRE
•
7:00am
Sep 10, 2020
AIM ImmunoTech to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14th
ACCESSWIRE
•
7:00am
Aug 28, 2020
Thinking about buying stock in Workday Inc, Walmart, HP, Microsoft, or AIM ImmunoTech Inc?
PRNewswire
•
11:01am
Aug 27, 2020
AIM ImmunoTech Inc. Decreases SARS-CoV-2 Infectious Viral Yields by 90% Using New In Vitro Model; Supports Further Testing of Ampligen as an Intranasal Prophylactic to Prevent COVID-19
ACCESSWIRE
•
11:00am
Aug 25, 2020
AIM ImmunoTech to Present at The LD 500 Virtual Conference on September 1st
ACCESSWIRE
•
7:00am
Aug 17, 2020
AIM ImmunoTech Provides Second Quarter 2020 Business Update and Reports Progress in Both COVID-19 and Cancer Trials
ACCESSWIRE
•
7:00am
Jul 27, 2020
AIM ImmunoTech to Present at the SNN Network Virtual Investor Conference on Monday, August 3rd
ACCESSWIRE
•
7:00am
Jul 09, 2020
AIM ImmunoTech Signs Clinical Trial Agreement with Roswell Park Comprehensive Cancer Center Supporting Phase 1/2 Clinical Trial of Ampligen Combined with Interferon Alfa-2b in COVID-19 Patients with Cancer
ACCESSWIRE
•
7:00am
Jul 06, 2020
AIM ImmunoTech Signs Material Transfer and Research Agreement with Japan's National Institute of Infectious Diseases and Shionogi, a Leading Global Pharmaceutical Company, to Test Ampligen as Potential Vaccine Adjuvant for COVID-19
ACCESSWIRE
•
11:00am
Jun 29, 2020
AIM ImmunoTech Added to Russell Microcap(R) Index
ACCESSWIRE
•
7:00am
Jun 26, 2020
Thinking about buying stock in Soligenix Inc, Ekso Bionics, SINTX Technologies, AIM ImmunoTech, or Nio Inc?
PRNewswire
•
11:01am
Jun 15, 2020
AIM ImmunoTech Provides Update on Commercial Launch of Ampligen(R) in Argentina for the Treatment of Chronic Fatigue Syndrome
hollywood1450
•
11:00am
Jun 11, 2020
AIM ImmunoTech Files Provisional Patent Application for the Use of Ampligen(R) as a Potential Therapy for COVID-19 Induced Chronic Fatigue
hollywood1450
•
11:00am
May 29, 2020
Thinking about buying stock in Adaptimmune Therapeutics, MEI Pharma, Dynavax Technologies, AIM ImmunoTech, or Meridian Bioscience?
PRNewswire
•
11:06am
May 14, 2020
Thinking about buying stock in AIM ImmunoTech, Wells Fargo, United Airlines, Altimmune, or TOP Ships?
PRNewswire
•
11:10am
AIM ImmunoTech Announces FDA Authorization for First Human Ampligen Trial in COVID-19 Patients with Cancer; Provides Corporate Business Update for the First Quarter of 2020
hollywood1450
•
7:00am
Apr 29, 2020
AIM ImmunoTech's CEO to Present at Maxim's Infectious Disease Virtual Conference
hollywood1450
•
7:00am
Apr 20, 2020
AIM ImmunoTech's CEO to Present at the Planet Microcap Showcase Virtual Investor Conference 2020
hollywood1450
•
7:00am
Total 79
1
2
Show
20
40
60
80
100
No data
Entries
Headlines
Total 0
1
No recent news